ATS 2019 Virtual Final Program

P168 Preclinical Manifestations of Atherosclerosis in the Carotid Arteries and Cardiovascular Dysfunction in Smokers and During the Early Stages of Chronic Obstructive Pulmonary Disease/ N. Vera, E. Kondrashova, D. Bogdanov, E. Shestopalov, Vladivostok, Russian Federation, p.A1604 P169 Smoking Pattern Differs Between Men and Women: A Potential Explanation for Gender Differences in Lung Disease Expression/ F. Polverino, A. Capuozzo, L. Di Buono, F. Ferrigno, I. Mauro, G. Cicchitto, M. Polverino, B.R. Celli, Tucson, AZ, p.A1605 P170 Association of Inhaled Corticosteroid Combination Adherence with Resource Use and Cost Among COPD Patients: A Retrospective Database Study/ R. Chen, Y. Gao, H. Wang, N. Shen, H. Shang, X. You, X. Ling, J. Xuan, Guangzhou, China, p.A1606 P171 Clinical Significance of COPD as a Risk Factor for Community-Acquired Pneumonia (CAP) and Healthcare-Associated Pneumonia (HCAP)/ S. Teramoto, M. Ishida, T. Ichiwata, Tokyo, Japan, p.A1607 P172 Prevalence of COPD Outpatient Based on COPD Diagnostic Questionnaire and Spirometry in Persahabatan General Hospital in Jakarta/ R. Ratnawati, Y.M. Kolewora, F. Yunus, A.D. Susanto, E. Samoedro, Jakarta, Indonesia, p.A1608 P173 Clinically Meaningful Reduction in Hyperinflation with Zephyr Endobronchial Valves (Zephyr Valve) Associated with Sustained Longitudinal Improvements in Lung Function, Exercise Tolerance, QoL and Dyspnea/ F.C. Sciurba, J.M. Bon, R. Sue, S. Wright, H. Rivas-Perez, T.A. Wiese, U.A. Gauhar, B.M. Morrissey, K.Y. Yoneda, H.G. Oliveira, A. Macedo, M.M. Wahidi, P.F.G. Cardoso, F.N.D. Oliveira, N.J. Pastis, C.B. Strange, M.T. Dransfield, S.P. Bhatt, S. Kemp, J.L. Garner, S. Radhakrishnan, N.S. Shargill, N. Marchetti, G.J. Criner, N. Hacken, D. Slebos, Pittsburgh, PA, p.A7308 P174 Impact of Zephyr Endobronchial Valves on Patient Reported Outcomes/ M.T. Dransfield, S.P. Bhatt, D.-J. Slebos, K. Klooster, F.C. Sciurba, P.L. Shah, J. Garner, S. Radhakkrishnan, N.S. Shargill, N. Marchetti, G. Criner, Birmingham, AL, p.A7309 BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION A42 CRITICAL CARE: WHERE THE SIDEWALK ENDS - NONCONVENTIONAL VENTILATION, HFNC, NIV AND ECMO 9:15 a.m. - 4:15 p.m. KBHCCD Area A (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitators : E. Fan, MD, PhD, Toronto, Canada B.K. Patel, MD, Chicago, IL P28 Early Experience with Heated Humidified High-Flow Oxygen Therapy for Acute Respiratory Failure in Adults/ V. Krishnan, J.D. Thornton, E. Sivak, Cleveland, OH, p.A1609 P29 Factors Predicting High-Flow Nasal Cannula Failure/ W. Lim, M.H.Y. Lee, S.J.W. Lew, J.A. Abisheganaden, S.H. Puah, Singapore, Singapore, p.A1610 P30 Comparing Heated High Flow Nasal Cannula vs. Conventional Modalities When Extubating Patients with Active Cancer and Advanced Liver Failure/ N. Iannazzo, M. Kult, S. Steele, K.J. Diab, Indianapolis, IN, p.A1611 P31 Recruitment Maneuver During Non-Invasive Ventilation in Coronary Artery Bypass Grafting Patients: Effect on Cost of Oxygen Supplementation/ C. Fu, Sao Paulo, Brazil, p.A1612 P32 Bedside Predictors of Successful Weaning from High-Flow Nasal Cannula Oxygen Therapy in Intensive Care Unit/ R. Coudroy, M. Rodriguez, R. Robert, J.-P. Frat, A. Thille, Poitiers, France, p.A1613 P33 Influence of the Noninvasive Ventilation Protocol on Intubation Rate in Patients with De Novo Acute Respiratory Failure: A Systematic Review of Randomized Trials/ R. Coudroy, M.A. Hoppe, R. Robert, F. Jean-Pierre, A.W. Thille, Poitiers, France, p.A1614 P34 Is Immunosuppression Status a Risk Factor for Noninvasive Ventilation Failure in Acute Hypoxemic Respiratory Failure?/ R. Coudroy, T. Pham, R. Robert, J.-P. Frat, A.W. Thille, Poitiers, France, p.A1615 P35 New Non Invasive Ventilation Initiation at a Large Tertiary Care Center/ P. Kahn, P. Marshall, J.M. Siner, New Haven, CT, p.A1616 P36 Introduction of an NIV Retrival Team into a District General Hospital/ V. Lewis, H. Jones, L. Ward, S. Fairbairn, Newport, United Kingdom, p.A1617 P37 Predicting Non-Invasive Ventilation Failure in Severe Acute Respiratory Distress Syndrome/ S. Harabaglia, M.J. Junqueira, Pueblo, CO, p.A1618 P38 Analysis of Survival and Mortality After Extracorporeal Membrane Oxygenation: the University of Alabama at Birmingham Experience/ K.M. Wille, R.P. Holt, V. Rusanov, N.S. Sharma, E. Diaz Zavala, S.C. Bellot, T.D. Lewis, J.K. Kirklin, C.W. Hoopes, V.G. Valentine, Birmingham, AL, p.A1619 P39 Extracorporeal Membrane Oxygenation (ECMO) in Severely Injured Patients with Acute Respiratory Distress Syndrome (ARDS): A 10-Year Institutional Experience/ M. Menk, C. Olbricht, R. Kleinwächter, S. Weber-Carstens, Berlin, Germany, p.A1620 Facilitators : D. Brodie, MD, New York, NY A. Abbasi, MD, Providence, RI P40 Clinical Impact of Interfaces in Chronic Respiratory Failure Treated with Non-Invasive Mechanical Ventilation/ D.E. López-Padilla, B. Recio Moreno, V. Gallo González, E.R. Jimeno, C. Castro Riera, A. Cerezo Lajas, J. Terán Tinedo, Z. Ji, S. López Martín, E. Ojeda Castillejo, L. Puente Mestu, Madrid, Spain, p.A1621 P41 Anticoagulation Effectiveness in Patients Undergoing Extracorporeal Membrane Oxygenation at a Single Center: A Retrospective Review/ T. Heacock, M. Lam, D. Lerner, K. Derry, R.L. Owens, La Jolla, CA, p.A1622 ATS 2019 • Dallas, TX SUNDAY • MAY 19 59 SUNDAY MORNING